pSivida Ltd. jetzt auch in Deutschland handelbar... - 500 Beiträge pro Seite
eröffnet am 27.10.03 06:52:31 von
neuester Beitrag 27.10.03 07:30:57 von
neuester Beitrag 27.10.03 07:30:57 von
Beiträge: 3
ID: 789.667
ID: 789.667
Aufrufe heute: 0
Gesamt: 365
Gesamt: 365
Aktive User: 0
Top-Diskussionen
| Titel | letzter Beitrag | Aufrufe |
|---|---|---|
| gestern 23:15 | 911 | |
| gestern 12:15 | 836 | |
| 20.04.24, 12:11 | 509 | |
| gestern 19:30 | 413 | |
| vor 49 Minuten | 404 | |
| heute 03:00 | 362 | |
| heute 05:38 | 343 | |
| vor 24 Minuten | 322 |
Meistdiskutierte Wertpapiere
| Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
|---|---|---|---|---|---|---|---|
| 1. | 1. | 18.039,13 | -0,27 | 200 | |||
| 2. | 2. | 9,5750 | -0,73 | 184 | |||
| 3. | 3. | 150,36 | -0,79 | 132 | |||
| 4. | 4. | 0,1900 | -2,06 | 70 | |||
| 5. | 6. | 0,0211 | -32,59 | 29 | |||
| 6. | 5. | 6,7320 | -0,18 | 29 | |||
| 7. | 7. | 1,3500 | -0,74 | 29 | |||
| 8. | 15. | 2,3780 | +0,93 | 26 |
Feedback
pSivida lists on the Frankfurt Stock Exchange
pSivida Limited (ASX: PSD) is pleased to announce that its common stock has been accepted for listing and trading on the Frankfurt Stock Exchange, commencing October 27th, 2003.
pSivida’s trading symbol on the XETRA (Electronic Dealing System) is PSI and the German securities code (WKN) is 358705.
.
pSivida Managing Director said, "Listing on the Frankfurt Exchange will increase the profile of pSivida with both private and institutional investors in Germany and across Europe and follows on from overseas institutional support received in the company’s recent capital raising.”
“This opportunity to broaden our shareholder base comes at an excellent time for the company as its continues to develop and commercialise the BioSiliconTM technology platform in Europe, while also providing important exposure and increased investor awareness leading up to the listing of pSiMedica on the London Stock Exchange (AIM or Mainboard) in 2004.
A multi-city roadshow has been planned for November in conjunction with the company’s European investor relations firm.
The Frankfurt Stock Exchange (FWB) is the largest of the eight German stock exchanges. It ranks third in the world behind the NYSE and NASDAQ. The launch of XETRA has offered its clients not only floor trading through brokers but also fully-electronic trading facilities, whereby orders from any point in the globe are automatically inputted into the order book on the central computer. The FWB is operated by Deutsche Borse AG.
For more information visit the Frankfurt Stock Exchange at:
http://deutsche-boerse.com.
-ENDS-
Released by:
Josh Mann
Investor Relations
pSivida Limited
Tel: + 61 8 9226 5099
joshuamann@psivida.com.au
NOTES TO EDITORS:
pSivida Limited
pSivida is an Australian-based biotechnology company committed to the biomedical applications of nano-technology and which has as its core focus the development and commercialisation of nano-structured porous silicon (BioSilicon™) in biocompatible and biodegradable forms for use in human and animal healthcare through its UK subsidiary pSiMedica Limited, and in conjunction with UK Government owned QinetiQ plc. As a true ‘platform technology’, BioSilicon™ has multiple potential applications across the high growth healthcare sector, including controlled drug delivery, tissue engineering and orthopaedics.
pSivida is listed on the Australian Stock Exchange (ASX Code: PSD). www.pSivida.com.au
pSivida Limited (ASX: PSD) is pleased to announce that its common stock has been accepted for listing and trading on the Frankfurt Stock Exchange, commencing October 27th, 2003.
pSivida’s trading symbol on the XETRA (Electronic Dealing System) is PSI and the German securities code (WKN) is 358705.
.
pSivida Managing Director said, "Listing on the Frankfurt Exchange will increase the profile of pSivida with both private and institutional investors in Germany and across Europe and follows on from overseas institutional support received in the company’s recent capital raising.”
“This opportunity to broaden our shareholder base comes at an excellent time for the company as its continues to develop and commercialise the BioSiliconTM technology platform in Europe, while also providing important exposure and increased investor awareness leading up to the listing of pSiMedica on the London Stock Exchange (AIM or Mainboard) in 2004.
A multi-city roadshow has been planned for November in conjunction with the company’s European investor relations firm.
The Frankfurt Stock Exchange (FWB) is the largest of the eight German stock exchanges. It ranks third in the world behind the NYSE and NASDAQ. The launch of XETRA has offered its clients not only floor trading through brokers but also fully-electronic trading facilities, whereby orders from any point in the globe are automatically inputted into the order book on the central computer. The FWB is operated by Deutsche Borse AG.
For more information visit the Frankfurt Stock Exchange at:
http://deutsche-boerse.com.
-ENDS-
Released by:
Josh Mann
Investor Relations
pSivida Limited
Tel: + 61 8 9226 5099
joshuamann@psivida.com.au
NOTES TO EDITORS:
pSivida Limited
pSivida is an Australian-based biotechnology company committed to the biomedical applications of nano-technology and which has as its core focus the development and commercialisation of nano-structured porous silicon (BioSilicon™) in biocompatible and biodegradable forms for use in human and animal healthcare through its UK subsidiary pSiMedica Limited, and in conjunction with UK Government owned QinetiQ plc. As a true ‘platform technology’, BioSilicon™ has multiple potential applications across the high growth healthcare sector, including controlled drug delivery, tissue engineering and orthopaedics.
pSivida is listed on the Australian Stock Exchange (ASX Code: PSD). www.pSivida.com.au
Welche WKN?
WKN 358705.
DurchsuchenBeitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
| Wertpapier | Beiträge | |
|---|---|---|
| 194 | ||
| 188 | ||
| 143 | ||
| 72 | ||
| 31 | ||
| 29 | ||
| 29 | ||
| 26 | ||
| 25 | ||
| 25 |
| Wertpapier | Beiträge | |
|---|---|---|
| 25 | ||
| 23 | ||
| 23 | ||
| 23 | ||
| 23 | ||
| 21 | ||
| 20 | ||
| 20 | ||
| 20 | ||
| 20 |
